PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PJP vs. XPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


PJPXPH
YTD Return15.50%13.20%
1Y Return28.19%33.34%
3Y Return (Ann)4.35%0.52%
5Y Return (Ann)8.92%5.00%
10Y Return (Ann)4.06%0.21%
Sharpe Ratio2.341.97
Sortino Ratio3.122.80
Omega Ratio1.391.33
Calmar Ratio1.740.85
Martin Ratio14.585.24
Ulcer Index2.04%6.44%
Daily Std Dev12.73%17.14%
Max Drawdown-37.06%-48.03%
Current Drawdown-2.07%-19.10%

Correlation

-0.50.00.51.00.9

The correlation between PJP and XPH is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

PJP vs. XPH - Performance Comparison

In the year-to-date period, PJP achieves a 15.50% return, which is significantly higher than XPH's 13.20% return. Over the past 10 years, PJP has outperformed XPH with an annualized return of 4.06%, while XPH has yielded a comparatively lower 0.21% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctober
11.64%
16.35%
PJP
XPH

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PJP vs. XPH - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is higher than XPH's 0.35% expense ratio.


PJP
Invesco Dynamic Pharmaceuticals ETF
Expense ratio chart for PJP: current value at 0.58% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.58%
Expense ratio chart for XPH: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

PJP vs. XPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PJP
Sharpe ratio
The chart of Sharpe ratio for PJP, currently valued at 2.34, compared to the broader market-2.000.002.004.006.002.34
Sortino ratio
The chart of Sortino ratio for PJP, currently valued at 3.12, compared to the broader market0.005.0010.003.12
Omega ratio
The chart of Omega ratio for PJP, currently valued at 1.39, compared to the broader market1.001.502.002.503.003.501.39
Calmar ratio
The chart of Calmar ratio for PJP, currently valued at 1.74, compared to the broader market0.005.0010.0015.001.74
Martin ratio
The chart of Martin ratio for PJP, currently valued at 14.58, compared to the broader market0.0020.0040.0060.0080.00100.00120.0014.58
XPH
Sharpe ratio
The chart of Sharpe ratio for XPH, currently valued at 1.97, compared to the broader market-2.000.002.004.006.001.97
Sortino ratio
The chart of Sortino ratio for XPH, currently valued at 2.80, compared to the broader market0.005.0010.002.80
Omega ratio
The chart of Omega ratio for XPH, currently valued at 1.33, compared to the broader market1.001.502.002.503.003.501.33
Calmar ratio
The chart of Calmar ratio for XPH, currently valued at 0.85, compared to the broader market0.005.0010.0015.000.85
Martin ratio
The chart of Martin ratio for XPH, currently valued at 5.24, compared to the broader market0.0020.0040.0060.0080.00100.00120.005.24

PJP vs. XPH - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 2.34, which is comparable to the XPH Sharpe Ratio of 1.97. The chart below compares the historical Sharpe Ratios of PJP and XPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctober
2.34
1.97
PJP
XPH

Dividends

PJP vs. XPH - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.88%, less than XPH's 1.50% yield.


TTM20232022202120202019201820172016201520142013
PJP
Invesco Dynamic Pharmaceuticals ETF
0.88%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%2.96%0.44%
XPH
SPDR S&P Pharmaceuticals ETF
1.50%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%5.55%2.06%

Drawdowns

PJP vs. XPH - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for PJP and XPH. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctober
-2.07%
-19.10%
PJP
XPH

Volatility

PJP vs. XPH - Volatility Comparison

The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 3.30%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 5.25%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctober
3.30%
5.25%
PJP
XPH